Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

[(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate

    • Product Name [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate
    • Alias Testosterone decanoate
    • Einecs 265-965-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    114780

    Iupac Name [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] decanoate
    Molecular Formula C39H66O2
    Molecular Weight 566.94 g/mol
    Cas Number 638-51-7
    Pubchem Cid 12694
    Physical State Oily liquid
    Appearance Clear, colorless to pale yellow liquid
    Boiling Point 531.1 °C at 760 mmHg (estimated)
    Density 0.95 g/cm³ (approximate)
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in most organic solvents
    Logp 8.01 (estimated)
    Smiles CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=C(C)C=CC[C@H]4[C@@H]3CC[C@]2(C)[C@H]1CC(C)CC
    Inchi InChI=1S/C39H66O2/c1-7-8-9-10-11-12-13-14-38(40)41-32-27-25-24-26-28-33(2)22-21-23-31(28)30(27)19-20-35(3)34(32)29-36(4,5)18-16-15-17-37(35)6/h21-23,27,29,32,34-35H,7-20,24-26H2,1-6H3/t27-,32-,34-,35-,36-,37-/m0/s1
    Synonyms Testosterone decanoate

    As an accredited [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 5-gram amber glass vial with a secure screw cap, labeled with the full chemical name, concentration, and safety information.
    Shipping This chemical, [(3S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] decanoate, is shipped in tightly sealed containers under temperature-controlled conditions. Proper labeling and documentation are ensured to comply with safety regulations and to prevent degradation or hazardous exposure during transit.
    Storage Store [(3S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] decanoate in a cool, dry, and well-ventilated area, away from direct sunlight, heat, and sources of ignition. Keep the container tightly closed and protected from moisture and incompatible substances such as strong oxidizing agents. Store in accordance with local regulations for organic compounds.
    Application of [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate

    Applications of [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate in Industrial Manufacturing

    Our factory supplies [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate as a steroidal ester widely adopted in multiple regulated sectors. Key downstream uses reflect strict process, safety, and compliance demands. Below we detail major application scenarios in our industrial buyer network, including regulatory, technical, and product integration specifics.

    1. Injectable Hormonal Pharmaceutical Preparations

    This compound serves as the active pharmaceutical ingredient (API) in long-acting injectable hormone therapeutics produced by contract drug manufacturing organizations and hospital outsourcing units. Advanced batch reactors blend the ester into oil bases, following cGMP protocols, with each batch requiring pre-release characterization of identity, purity, content uniformity, and particle sizing. Product development teams adjust dissolution rates through precise ratio setting, based on clinical dosing schedules and pharmacokinetic profiling for depot effect. The final solution is filtered, aseptically filled, and packed in FDA-compliant glass ampoules or vials, with each lot undergoing pharmacopoeia assay and sterility testing before release.

    Industry compliance standards

    • U.S. FDA 21 CFR Parts 210–211; Drug GMP
    • ICH Q7: Good Manufacturing Practice for APIs
    • USP Monograph for Intramuscular Steroid Injections
    • EMA EudraLex Vol 4 (EU GMP); Annex 1 for Sterile Medicinal Products

    Typical usage ratio

    • API loading at 200–400 mg/mL in matrix oil phase
    • Ratio varies with pharmacokinetic goals and solvent system (e.g., castor or sesame oil base)

    Downstream process integration

    • Added post-sterilization through continuous mixing vessel
    • Identity confirmation and impurity profile established prior to filling
    • In-process controls include viscosity and content uniformity analysis

    Final product types

    • Pre-filled injectable vials for human hormone therapy
    • Glass ampoules for hospital formulary supply
    • Multi-dose injectables for clinics and pharmacies

    2. Veterinary Hormone Formulations

    Veterinary pharmaceutical manufacturers utilize this decanoate ester to formulate controlled-release hormonal treatments for livestock and companion animals. The raw material's stability under sterilization allows inclusion during the oil phase compounding step, using stainless steel mixing tanks equipped for inert gas blanketing. Concentration adjustments depend on target species, weight, and veterinary protocol, with strict adherence to VICH and OIE guidelines for animal health products. Batch release requires analytical confirmation against veterinary pharmacopoeia specifications, with final applications in regulated livestock health management systems.

    Industry compliance standards

    • VICH GL9 (Good Manufacturing Practice for Veterinary Medicines)
    • Chinese Veterinary Pharmacopoeia (CVP)
    • EU Regulation (EC) No 470/2009 (MRLs for Veterinary Medicines)
    • US FDA Center for Veterinary Medicine (CVM) cGMP

    Typical usage ratio

    • API content typically 50–250 mg/mL per formulation
    • Dosage based on target animal species (bovine, equine, canine, etc.)

    Downstream process integration

    • Added during intermediate compounding in jacketed mixers
    • Sterilized via filtration, then filled into multi-use containers
    • Routine QC for residual solvents, sterility, and API assay

    Final product types

    • Injectable veterinary hormone solutions
    • Livestock reproductive agents
    • Endocrine therapies for companion animals

    3. API Intermediate for Finished Hormone Formulation Plants

    API intermediate processors procure this steroidal decanoate ester for custom conversion into further esterified or micronized derivatives needed by downstream finished formulation facilities. Technical teams hydrolyze, re-crystallize, or transesterify the molecule in closed-system reactors, observing strict environmental controls as outlined by national pharmaceutical authorities. End-to-end chain of custody documentation is mandatory, with process optimization focusing on yield, purity, and elimination of process-related impurities, meeting stringent finished drug registration requirements in multiple jurisdictions.

    Industry compliance standards

    • ICH Q7 and Q11 for API manufacturing and intermediates
    • China NMPA Drug Registration Regulations
    • EHS permitting under REACH framework
    • ISO 9001:2015 for pharmaceutical quality management systems

    Typical usage ratio

    • Batch conversion input at 70–90% purity by weight
    • Adjusted by required derivative content and conversion efficiency

    Downstream process integration

    • Introduced as initial charge in reaction vessels for further chemical modification
    • Quality-checked for volatility, solubility, and impurity content before use
    • Transformation proceeds under controlled pH and temperature profiles

    Final product types

    • Pharmaceutical-grade hormone API crystals
    • Micronized steroid powders
    • Custom API blends for contract suppliers

    4. Analytical Reference Standards Production

    Specialty chemical analysis suppliers require high-purity batches of this compound to serve as primary or secondary reference standards for regulated laboratories, clinical trial sponsors, and quality control departments. Traceable preparation workflows carefully purify and standardize batches against pharmacopeial and ISO Committee on Reference Materials (ISO/REMCO) guidelines. Labs use these certified standards in analytical validation for method development, stability testing, and regulatory submissions, with each lot supported by full certificate of analysis (COA), including HPLC purity, residual solvents, and identification by NMR and MS.

    Industry compliance standards

    • USP General Chapter <1151> Reference Standards
    • ISO Guide 34 / ISO 17034 (Reference Material Producers)
    • ICH Q6A Specifications: Test Procedures and Acceptance Criteria
    • FDA CFR Title 21, Part 58 (Good Laboratory Practice)

    Typical usage ratio

    • Used at microgram to milligram levels depending on method validation needs
    • Batches certified to ≥99.7% HPLC purity, with precise gravimetric adjustment

    Downstream process integration

    • Certified and subdivided in ISO Class 7 cleanrooms
    • Portioned into moisture-proof ampoules or vials
    • Stability testing extends across multiple temperature and humidity conditions

    Final product types

    • Primary and secondary analytical reference standards
    • Calibration samples for HPLC, GC, and MS laboratories
    • Validation standards for clinical research organizations

    5. Bulk Hormone Premix Manufacturing for Licensed Compounding Pharmacies

    Licensed compounding pharmacies source this ester as a regulated raw material for preparation of custom hormone preparations according to individual prescriptions or institutional use protocols. Compounding technicians blend the ester under laminar flow hoods, strictly adhering to USP <795>, <797>, and local regulatory mandates. Dosage form and API ratio are determined by prescriber specifications, with rigorous lot tracking and adverse event reporting protocols in place. Quality control involves in-house testing of raw material identity, particle size for injectables, and dissolution for oral suspensions. Each batch receives a dedicated lot code and expiration assignment before dispensing to end users.

    Industry compliance standards

    • USP <795> (Non-Sterile Compounding); USP <797> (Sterile Compounding)
    • U.S. DEA Schedule III Controlled Substance Regulations
    • State Board of Pharmacy Compounding Rules (e.g., Texas, California BOP)
    • FDA Human Drug Compounding Outsourcing Facility 503B standards

    Typical usage ratio

    • 200–400 mg per individual dose for injectables, titrated as prescribed
    • Bulk oil suspensions at 1–5% active content for clinic dispensing

    Downstream process integration

    • Dissolved in measured sterile oils, thoroughly homogenized with aseptic mixing equipment
    • Filled into unit-dose syringes or multidose containers in compounding suites
    • Lot-level documentation for traceability and regulatory reporting

    Final product types

    • Custom injectable therapies for hormone replacement protocols
    • Individualized hormone vials for medical office use
    • Hormone suspension kits for patient-specific compounding
    Free Quote

    Competitive [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate: Behind the Scenes of a High-Purity Specialty Ester

    A Chemist’s View on Sourcing and Manufacturing

    Working in chemical manufacturing teaches a hands-on respect for each molecule. We have spent years refining the production of [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate. Feedback from formulators and pharmaceutical developers guides every part of our operation. Every batch of this specialty ester passes through layers of quality checkpoints, reflecting the strict tolerances demanded by advanced applications in research and health science. There’s an art in translating theoretical chemistry into usable, scalable production—one that our technicians have cultivated through trial, error, and years of collaboration with scientists in different fields.

    Chemical Identity, Molecular Model, and Key Specifications

    On the synthesis floor, this compound stands out both for its complexity and its unique properties in biological and synthetic processes. The molecular formula, reflecting a steroid skeleton esterified at the 3-beta position with decanoic acid, offers both utility and challenge. Exacting conditions and clean-room protocols keep side products and contamination to a minimum. Each gram is the result of solvent selection, precise temperature control, and the patience to let crystallization finish at its own pace. We authenticate molecular structure with full spectroscopic characterization—NMR, IR, GC, HPLC—always delivering batch certificates with every shipment.

    Experienced analysts recognize its pale color and characteristic melting range. Strict moisture and impurity thresholds ensure reliability for downstream synthesis or analytical uses. We deliver material within agreed specifications—assay, sterility, and residual solvent content—because inconsistency in active compounds slows research.

    Why Decanoate Esters Matter in Practice

    Long-chain esters like this one weren’t always standard in pharmaceutical research. Direct handling of the parent alcohol or acid can lead to rapid metabolic turnover or formulation instability. Conjugation with a ten-carbon decanoic acid chain solves several problems at once: improved solubility in organic vehicles, controlled release in depot formulations, and shielding of sensitive alcohol groups from early degradation. As one of our earliest pharmaceutical partners put it, “You can’t run a repeatable trial if you can’t trust your starting material.” Our production floor works with that reality in mind.

    This decanoate ester moves beyond lab curiosities. In hormonal drug development, for example, esterification with decanoic acid enables sustained activity after intramuscular injection, providing dosing consistency and simplifying clinical protocols. We have supported research projects focused on new therapies, where reproducibility and batch-to-batch identity allow lab teams to isolate variables without second-guessing their reagents. The trust researchers place in our product isn’t abstract—they share their methods, results, and even setbacks, which helps us refine both purity and physical properties.

    Practical Handling and Storage Insights

    Lab workers give direct feedback which rarely shows up in textbooks. This compound keeps best under low-humidity conditions, away from light and high temperatures. For bulk customers, we supply sturdy, airtight containers that handle transit shocks and tight warehouse spaces. Our team tracks every shipment and provides sealed reference samples, since disputes about material quality need decisive evidence. No one wants a delayed analytical project because of avoidable storage mistakes. Having seen how improper handling ruins compound integrity, we’ve developed clear protocols and trained logistics staff to avoid costly errors. Our records trace every delivery and sample—from plant to customer, with timestamps and storage logs, to support full transparency and traceability.

    How Our Material Stands Apart

    Not all steroidal esters behave the same way. Our [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate offers distinct performance in pharmaceutical and biotech formulations. Small details—hydrate levels, byproducts of side reactions, processing solvent residues—change stability in finished products. Our process eliminates non-decanoate esters and short-chain byproducts, keeping composition pure. Colleagues in R&D care about these points because they directly affect shelf life and activity curves. Our understanding grows with every customer question, complaint, or validation study shared with us, leading to continuous process improvements.

    Other suppliers sometimes cut corners, recycling solvents or batch-joining for higher yields. We run smaller lots, take cleaning seriously, and discard borderline material rather than risk contaminating downstream syntheses. Years of working with hormone research labs have taught us how a single impurity, undetected in routine analysis, can throw off pharmacokinetic profiles and regulatory reviews. Our quality team works closely with production, not just reviewing paperwork, but walking the lines and testing samples mid-process. We never treat quality control as a box to tick; every batch must meet expectations because we know scientists are relying on our compounds to generate actionable results.

    Lessons Learned from Working Directly with Researchers

    Pharmaceutical developers keep us honest and thorough. Clinical trials rely on reproducible starting reagents for active pharmaceutical ingredients. Once, a client redesigned their depot formula using our decanoate ester after trials with another manufacturer failed due to unexpected breakdown in storage. They shared analytical chromatograms with us, showing how a small impurity changed the time-release curve. That sparked a round of internal process reviews and equipment upgrades, leading to even tighter control of our final product. Such partnerships make our work worthwhile and keep us at the cutting edge of what real-world applications demand.

    Providing a reference compound for an emerging analytical method or a new drug application brings its own challenges. We collaborate with lab staff who explain their goals, share data, and challenge our assumptions. Sometimes we run extra panels—stability under temperature cycling, response in non-standard solvents, or compatibility with novel excipients—because these details matter once material leaves the factory. Our support does not stop at shipping—ongoing dialogue with research teams cycles back into improved benchmarks, both for purity and documentation.

    Down-to-Earth Details on Batch Consistency and Problem Solving

    One day on the synthesis floor, a batch produced a faint but odd odor—a warning flag in any regulated compound. Rather than ship the lot as usual, we ran deeper analysis and found trace solvent retention from a previous cleaning. The entire team stopped production, traced the source, and improved our rinse verification with a more sensitive analytical method. The batch was rejected, and the event became a training point for new operators. These small incidents, while costly in lost product and time, build a stronger foundation of trust with our clients. We’d rather discard questionable material than risk someone’s clinical trial or product launch.

    Shipping around the world adds complexity. Containers must resist moisture, stacking, and rough customs inspections. We learned to add silica gel packs, double-seal containers, and use tamper-evident banding, all in response to real customer feedback. We share these best practices with clients, especially those running niche labs or setting up storage in humid climates. When a shipment runs late or is held in customs, we intervene personally to prevent temperature excursions and track samples by hand if needed. Our partners know they can call us—not a generic hotline—and reach someone who understands both chemistry and the challenges of real-world logistics.

    From Routine Manufacturing to Novel Research Applications

    Some users approach us for highly specialized needs. Analytical standards for reference labs must come with full characterization and documentation. Regulatory filings demand robust data trails—every analysis, method, and batch record audited and verified. Generic, bulk commodity producers rarely address these technical needs. By maintaining a team with expertise in both synthetic chemistry and regulatory standards, we support novel applications and keep up with evolving industry demands. Our process documentation stands ready for both internal audits and third-party review, building mutual confidence in every lot shipped for reference or clinical use.

    Our team remains active in field trials and application support, participating in research consortia and public projects whenever possible. Sharing best practices, staying current with literature, and exchanging findings in technical forums supports both our growth and that of our customers. This ongoing cycle of improvement matches the dynamic needs of new drug development, analytical science, and specialty materials research.

    Insights into Raw Material Sourcing and Production Stability

    Reliable production depends on more than clean rooms. Sourcing raw steroidal alcohols and pharmaceutical-grade decanoic acid can be unpredictable as global supply chains shift. We maintain stable alliances with trusted producers who demonstrate consistent analytical records, transparent supply histories, and a willingness to address sudden market pressures. If a raw material batch falls out of spec, we run additional screens and adjust our stockpiling strategies. Over-preparing beats scrambling when timelines for deliveries tighten. These approaches have saved projects for clients needing last-minute orders and for ongoing long-term supply contracts.

    Working with our partners, we’ve learned to anticipate market swings and collaborated on backup sourcing. When COVID-19 pressured international shipping, we implemented buffer stocks and agile logistics. Our facility renovations, including new solvent recovery and in-line drying, directly reflect these lessons. Transparent communication with clients, especially about delays or batch anomalies, keeps everyone informed. We never hide problems or hope issues resolve themselves; timely, honest updates build long-term business relationships and keep research and development teams on track.

    Distinct Features in Contrast to Shorter-Chain and Other Esters

    This decanoate ester consistently stands out compared to shorter-chain analogs and non-steroidal esters. In practice, longer-chain esters provide greater lipophilicity, slower hydrolysis rates, and enhanced depot duration in parenteral applications. While some formulators still experiment with enanthate or propionate derivatives, feedback overwhelmingly favors decanoate for its optimal release profile and minimal injection-site irritation. Formulators and clinical scientists appreciate the minimized peak-trough fluctuation in active drug concentrations achieved with longer-acting esters.

    We produce other esterified compounds and have seen first-hand the variations in solubility, metabolic fate, and formulation behavior. A single methylene group can dramatically shift pharmacokinetics or analytical response. Our expertise in this class of steroids fits these nuanced differences into the broader context of formulation science and regulatory compliance. Tighter impurity tracking and improved analytical profiles support clearer regulatory pathways and safer end-use products.

    Shared Goals Across Industry and Research Sectors

    Pharmaceuticals, analytical chemistry, and even advanced materials research depend on tight tolerances and fully traceable production environments. For any given compound, especially those destined for clinical research, manufacturing integrity means more than numbers on a certificate. It comes down to transparency, responsive customer service, and a genuine understanding of each client’s application. Our chemists regularly troubleshoot issues in analytical labs, support formulation changes, and advise on best handling practices, acting as partners rather than faceless suppliers.

    Direct engagement with formulation scientists improves the reference value of every gram shipped. If a customer’s team uncovers an anomaly, our technical experts listen, investigate, and adapt, providing more than a generic customer service script. This approach to partnership underpins everything from method development to documentation audits, supporting both regulatory approvals and innovative R&D goals.

    Preparing for Future Demands and New Technologies

    Sophisticated compounds like [(3S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1H-Cyclopenta[A]Phenanthren-3-Yl] Decanoate might one day see new application as analytical standards, controlled release agents, or specialized tools in synthetic biology. Our manufacturing team tracks global trends, keeping pace with shifting analytical standards, new excipient developments, and evolving regulatory demands. Every improvement—whether in sustainability, waste minimization, or advanced purification—feeds directly back into product performance and compliance.

    We expect that new therapeutic directions, such as targeted delivery or tissue-specific depot formulations, will call for the highest purity and traceable provenance. Our processes, documentation, and customer service reflect a commitment to supporting those innovations. By keeping quality standards high and learning from user experiences, we lay the groundwork for future collaborations and new breakthroughs across research and health science sectors.

    Closing Insights from a Manufacturer’s Perspective

    This compound, with its technical name and complex structure, means little outside the world of synthetic and analytical chemistry. To those of us producing and supplying it, though, each batch is the result of experience, ongoing learning, and partnership with users around the world. From sourcing to synthesis, from quality control to logistics, every step brings lessons that feed back into stronger, more reliable offerings for both new research and established applications. We value this work not just as a process, but as a shared mission with the scientists and developers who depend on consistent, high-purity material to push discovery and innovation forward.